340b Health
DC · 24 filings, 2025
What the money shows
340b Health reported $1.4M in federal lobbying for 2025 across 24 filings. The filings name 6 lobbying firms, led by 340b Health and Veritas Health Policy. The filing text lists 3 issue areas.
Sources: Senate LDA · FEC
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services." Maintaining services and lowering medication costs for patients is consistent with the purpose of the program, which is named for the section authorizing it in the Public Health Service Act (PHSA). It was enacted by Congress as part of the Veteran's Health Care Act of 1992 and codified in Section 340B of the PHSA, signed into law by President George H. W. Bush. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Pharmacy · Medicare/Medicaid
2Through these firms · 6
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews